A concise display of multiple end points for benefit-risk assessment.
about
Within-drug benefit-risk evaluation of olanzapine long-acting injection at one and two years of treatmentBenefit-risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia.Application of the BRAT Framework to Case Studies: Observations and Insights
P2860
A concise display of multiple end points for benefit-risk assessment.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
A concise display of multiple end points for benefit-risk assessment.
@en
A concise display of multiple end points for benefit-risk assessment.
@nl
type
label
A concise display of multiple end points for benefit-risk assessment.
@en
A concise display of multiple end points for benefit-risk assessment.
@nl
prefLabel
A concise display of multiple end points for benefit-risk assessment.
@en
A concise display of multiple end points for benefit-risk assessment.
@nl
P2860
P356
P1476
A concise display of multiple end points for benefit-risk assessment.
@en
P2093
P2860
P356
10.1038/CLPT.2010.251
P407
P577
2010-11-24T00:00:00Z